Evidence map›Paper›PMID 42152918›Full record

ArticleJournal of chiropractic medicine2025

Platelet Rich-Plasma in MRI-Confirmed Tear of Posterior Cruciate Ligament: 4-Year Follow-up Case Report.

Ivan Medina-Porqueres, Pablo Martin-Garcia, Sofia Sanz-De Diego, Marcelo Reyes-Eldblom, Rafael Mondragon-Cortes, Daniel Rosado-Velazquez, Abel Gomez-Caceres

Abstract readCase Reports
In one paragraph

Article in Journal of chiropractic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ivan Medina-PorqueresDepartment of Physical Therapy, Faculty of Health Sciences, University of Malaga, Medical Services, Malaga Football Club, Malaga, Spain.
Pablo Martin-GarciaOnco-Hematology Unit, University Hospital Virgen de la Victoria, Malaga, Spain.
Sofia Sanz-De DiegoPuerperium Unit, Regional Hospital of Malaga, Malaga, Spain.
Marcelo Reyes-EldblomRegenerative Medicine Unit, Costa del Sol Medical Center Torremolinos, Malaga, Spain.
Rafael Mondragon-CortesMedical Services, Malaga Football Club, Malaga, Spain.
Daniel Rosado-VelazquezDepartment of Physical Therapy, Faculty of Health Sciences, University of Malaga, Medical Services, Malaga Football Club, Malaga, Spain.
Abel Gomez-CaceresDepartment of Physical Therapy, Faculty of Health Sciences, University of Malaga, Medical Services, Malaga Football Club, Malaga, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The purpose of this case report is to describe the management of a professional soccer player with a knee Posterior Cruciate Ligament (PCL) tear using platelet-rich plasma (PRP) injections. Clinical Features: A case of magnetic resonance imaging (MRI) confirmed type II injury of PCL with correlated physical signs of PCL insufficiency in a 21-year-old, white, professional soccer player is reported herein. Intervention and Outcome: A PRP regimen was administered intra-articularly in 3 applications at weekly intervals to the affected knee. Follow-up assessment showed complete, pain-free ROM, a clinically normal joint, and complete ligament healing after PRP. The healing was supported by magnetic resonance imaging performed 48 months after the treatment. Conclusion: This is the first reported case of a PCL type II injury in a professional soccer player with an isolated PRP application. This case expands the treatment options for PCL injuries and highlights another potential effect of PRP within the field of regenerative medicine.

Indexed as

Diagnostic ImagingFootballGrowth factorsKnee

Identifiers

PMID42152918
PMCPMC12803963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.